.After F2G's initial try to acquire a brand-new course of antifungal to market was thwarted by the F...
.Moderna has actually sworn to reduce R&D costs through $1.1 billion through 2027. The choice to ...
.Merely 4 months after Sanofi bet $80 million in upfront cash on Key Therapies' losmapimod, the plan...
.Cancer firm Oncternal Rehabs is folding all its own clinical trials as well as giving up personnel,...
.Roche is storing out hopes that its injectable excessive weight possibility can ultimately illustra...
.Novo Nordisk has actually lifted the lid on a phase 1 test of its own dental amylin as well as GLP-...
.Only a few quick weeks after succeeding an FDA Fast Track tag for its own investigational BTK degra...
.Shortly after a good records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based company i...
.BridgeBio Pharma is actually slashing its gene treatment spending plan as well as pulling back comi...
.GSK's effort to develop the 1st vaccine for genital herpes simplex infection (HSV) has ended in fai...